Replies to post #531414 on NorthWest Biotherapeutics Inc (NWBO)

[Bob_LobLaw]

Put on notice because the 10q stated they are considering switching their car insurance to Geico? I do not think the “manipulators” are concerned. They attack because they can. The company continues to make zero effort in marketing this company to the broader financial markets. 2+ years since data lock and still nobody knows about DC-VAX. We have repeatedly heard that the journal will have no effect on regulatory approvals. And we are supposedly well on our way to getting supposed approvals (not buying that at all). So if we have kept our mouths shut because of journal embargos which aren’t going to help us get approvals we are on the cusp of getting anyway then all we did was prevent ourselves from raising our stock price which would then allow us to lessen the sting of nonstop dilution at piss poor stock prices.

People are benefitting from the depressed stock price and until that gravy train runs out we are likely going no where.

[SkyLimit2022]

SNO and the publication of the independent peer review will both be celebrations of the truth. Truth matters in science and medicine. The peer review process is designed to safeguard truth and the integrity of scientific data and findings.

Disinformation is not harmless. An obstructed view of the truth can result in injury, loss of life, or the missed opportunity for healing.

The Earth exists in the shape of a sphere and science has proven that fact, but some will argue otherwise if their lie helps them to gain a few dollars.

[Poor Man -]

I’ve already informed the park patrons that I may be handing over my bench by the end of the week. Might take a little work to disassemble the African inspired boma I built — at your recommendation!

[dstock07734]

Exactly!
Last year 2153 professionals from 36 countries attend the meeting. This year there should more attendees. Pretty sure the reviewers of the journal paper will also show up. Maybe some of them reviewed the abstract too. It is a tremendous achievement to have abstract accepted for oral presentation given that only less than six abstract can be selected for the presentation. I have trouble in guessing which abstract award Linda Liau will get since there are many categories.

https://www.eventscribe.net/2021/SNO/aaStatic.asp?SFP=V05CTVVCV0RAOTQ1OUBBd2FyZCBSZWNpcGllbnRzLVRpbGU

BTW, Linda Liau's colleague Timothy Cloughesy who found that there is a transient window of opportunity in using PD1-inhibitor won the Victor Levin Award last year. Timothy is also responsible for the undergoing combination trial of DcVax with Keytruda.

https://wfnos.org/society-of-neuro-oncology-2021-annual-meeting-update/